Carlo Marani

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Polypharmacy and potentially inappropriate medications in patients requiring palliative care in hospitals and nursing homes: Evidence from a Ligurian point-prevalence multicenter study.

Polypharmacy and potentially inappropriate medications in patients requiring palliative care in hospitals and nursing homes: Evidence from a Ligurian point-prevalence multicenter study.

Journal: Maturitas
Published: August 28, 2025

Prevalence of Palliative Care Needs in Older Adults With Multimorbidity: A Multicentric Point Prevalence Study.

Prevalence of Palliative Care Needs in Older Adults With Multimorbidity: A Multicentric Point Prevalence Study.

Journal: Journal of the American Medical Directors Association
Published: May 04, 2023

Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography.

Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: March 19, 2018

Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.

Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: July 17, 2017

Haploidentical bone marrow transplantation in patients with advanced myelodysplastic syndrome.

Haploidentical bone marrow transplantation in patients with advanced myelodysplastic syndrome.

Journal: American journal of hematology
Published: December 24, 2016

Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.

Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.

Journal: Annals of hematology
Published: December 01, 2013

De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".

De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".

Journal: Annals of hematology
Published: February 13, 2013

Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia.

Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia.

Journal: Leukemia research
Published: February 01, 2013

Evaluating treatment response of chronic myeloid leukemia: emerging science and technology.

Evaluating treatment response of chronic myeloid leukemia: emerging science and technology.

Journal: Current cancer drug targets
Published: November 21, 2012

Nucleophosmin gene-based monitoring in de novo cytogenetically normal acute myeloid leukemia with nucleophosmin gene mutations: comparison with cytofluorimetric analysis and study of Wilms tumor gene 1 expression.

Nucleophosmin gene-based monitoring in de novo cytogenetically normal acute myeloid leukemia with nucleophosmin gene mutations: comparison with cytofluorimetric analysis and study of Wilms tumor gene 1 expression.

Journal: Leukemia & lymphoma
Published: April 06, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026